Case Reports
Vol. 3 No. 3 (2024)
Impaired platelet function in Hermansky-Pudlak syndrome associated with novel mutations in HPS3, HPS6 and HPS8 genes
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Received: 23 July 2024
Accepted: 18 October 2024
Accepted: 18 October 2024
1065
Views
254
Downloads
Authors
We report three unrelated cases of Hermansky-Pudlak (HP) characterized by novel mutations in HPS3 (compound heterozygosity for c.1457G>A and c.1813G>T), HPS6 (homozygous c.210_211insGGGCC), and HPS8 (homozygous c.299dupC in BLOC1S3) genes. No spontaneous bleeding tendency was observed despite the presence of several platelet function abnormalities. Screening test with PFA-100 failed to detect the abnormality. This report confirms the pattern of poor bleeding risk in patients with rare HP and the need for detailed platelet function studies despite normal hemostatic screening tests.
Downloads
Download data is not yet available.
Citations
Hermansky, F., & Pudlak, P. (1959). Albinism associated with hemorrhagic diathesis and unusual pigmented reticular cells in the bone marrow: report of two cases with histochemical studies. Blood, 14, 162–169. https://doi.org/10.1182/blood.V14.2.162.162 DOI: https://doi.org/10.1182/blood.V14.2.162.162
Merideth MA, Introne WJ, Wang JA, O'Brien KJ, Huizing M, Gochuico BR. Genetic variants associated with Hermansky-Pudlak syndrome. Platelets. 2020 May 18;31(4):544-547. doi: 10.1080/09537104.2019.1663810. Epub 2019 Sep 5. PMID: 32436471; PMCID: PMC8336198. DOI: https://doi.org/10.1080/09537104.2019.1663810
Nurden P, Stritt S, Favier R, Nurden AT. Inherited platelet diseases with normal platelet count: phenotypes, genotypes and diagnostic strategy. Haematologica. 2021 Feb 1;106(2):337-350. doi: 10.3324/haematol.2020.248153. PMID: 33147934; PMCID: PMC7849565. DOI: https://doi.org/10.3324/haematol.2020.248153
Dupuis A, Bordet JC, Eckly A, Gachet C. Platelet δ-Storage Pool Disease: An Update. J Clin Med. 2020 Aug 4;9(8):2508. doi: 10.3390/jcm9082508. PMID: 32759727; PMCID: PMC7466064. DOI: https://doi.org/10.3390/jcm9082508
Bowman M, Riddel J, Rand ML, Tosetto A, Silva M, James PD. Evaluation of the diagnostic utility for von Willebrand disease of a pediatric bleeding questionnaire. J Thromb Haemost. 2009 Aug;7(8):1418-21. doi: 10.1111/j.1538-7836.2009.03499.x. Epub 2009 May 30. PMID: 19496919. DOI: https://doi.org/10.1111/j.1538-7836.2009.03499.x
Lohse J, Gehrisch S, Tauer JT, Knöfler R. Therapy refractory menorrhagia as first manifestation of Hermansky-Pudlak syndrome.. Hamostaseologie. 2011 Nov; Suppl 1: S61-3. PMID: 220557877. DOI: https://doi.org/10.1055/s-0037-1619752
Cordova A, Barrios NJ, Ortiz I, Rivera E, Cadilla C,, Santiago-Borrero PJ. Poor response to desmopressin acetate (DDAVP) in children with Hermansky-Pudlak syndrome. Pediatr Blood Cancer. 2005 Jan; 44(1). Doi: 10.1002/pbc.20210. PMID: 15368543. DOI: https://doi.org/10.1002/pbc.20210
How to Cite
1.
Pieri L, Linari S, Salvianti F, Attanasio M, Castaman G. Impaired platelet function in Hermansky-Pudlak syndrome associated with novel mutations in HPS3, HPS6 and HPS8 genes. Bleeding Thromb Vascul Biol [Internet]. 2024 Nov. 27 [cited 2026 Jan. 27];3(3). Available from: https://www.btvb.org/btvb/article/view/150
Copyright (c) 2024 The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Similar Articles
- PO82 | Retrospective application of the TH2 score in a multicenter cohort of ITP patients: a reliable predictive tool or a score in need of refinement? , Bleeding, Thrombosis and Vascular Biology: Vol. 4 No. s1 (2025)
- PO27 | B-cell lymphoproliferative disorder and acquired coagulopathy: an insidious link , Bleeding, Thrombosis and Vascular Biology: Vol. 4 No. s1 (2025)
- Stefania Momi, Giuseppe Guglielmini, Giulia Ciarroca Taranta, Elisa Giglio, Angela Monopoli, Paolo Gresele, A nitric oxide-donor pravastatin hybrid drug exerts antiplatelet and antiatherogenic activity in mice , Bleeding, Thrombosis and Vascular Biology: Vol. 1 No. 2 (2022)
- CO15 | Longitudinal coagulation profiling of individuals undergoing gender-affirming hormone therapy: the hyper-gender study , Bleeding, Thrombosis and Vascular Biology: Vol. 4 No. s1 (2025)
- PO77 | The clinical awareness of mixing test interpretation in the era of complex reporting algorithm: do we forget the origins? , Bleeding, Thrombosis and Vascular Biology: Vol. 4 No. s1 (2025)
- CO24 | Extracellular vesicles profiles in patients with wild-type transthyretin amyloidosis , Bleeding, Thrombosis and Vascular Biology: Vol. 4 No. s1 (2025)
- CO02 | Hepatic fibrosis as predictor of cancer-associated thrombosis in patients with intrahepatic cholangiocarcinoma , Bleeding, Thrombosis and Vascular Biology: Vol. 4 No. s1 (2025)
- CO42 | Oxidative stress may contribute to enhanced thrombopoiesis through miR-150: implications for aspirin response , Bleeding, Thrombosis and Vascular Biology: Vol. 4 No. s1 (2025)
- CO19 | Hypercoagulability in wild-type transthyretin amyloidosis: evidence from whole blood thromboelastometry , Bleeding, Thrombosis and Vascular Biology: Vol. 4 No. s1 (2025)
- PO69 | Whole blood thrombin generation hypercoagulable profile in a patient with hemolytic crisis due to paroxysmal nocturnal hemoglobinuria: a case report , Bleeding, Thrombosis and Vascular Biology: Vol. 4 No. s1 (2025)
You may also start an advanced similarity search for this article.
Most read articles by the same author(s)
- Marco Marietta, Giancarlo Castaman, Comments on “Safe and effective anticoagulation use: case studies in anticoagulation stewardship” , Bleeding, Thrombosis and Vascular Biology: Vol. 4 No. 2 (2025)
- Giovanni Di Minno, Gaia Spadarella, Ilenia Lorenza Calcaterra, Giancarlo Castaman, Paolo Simioni, Raimondo De Cristofaro, Cristina Santoro, Flora Peyvandi, Matteo Di Minno, The evolving landscape of gene therapy for congenital severe hemophilia: a 2024 state of the art , Bleeding, Thrombosis and Vascular Biology: Vol. 3 No. 2 (2024)
- Giancarlo Castaman, Gene transfer in hemophilia B: a big step forward , Bleeding, Thrombosis and Vascular Biology: Vol. 2 No. 2 (2023)
- Silvia Linari, Renato Marino, Marzia Leotta, Antonio Coppola, Patrizia Di Gregorio, Augusto Bramante Federici, Flora Peyvandi, Cristina Santoro, Ezio Zanon, Rita Carlotta Santoro, The landscape of rare coagulation factor deficiency management in Italy: a national hemophilia center survey , Bleeding, Thrombosis and Vascular Biology: Vol. 4 No. 3 (2025)
- Renato Marino, Silvia Linari, Marzia Leotta, Antonio Coppola, Chiara Biasoli, Maria Elisa Mancuso, Flora Peyvandi, Cristina Santoro, Ezio Zanon, Rita Carlotta Santoro, Diagnostic and management practices for inherited fibrinogen disorders: a nationwide survey of Italian Hemophilia Treatment Centers , Bleeding, Thrombosis and Vascular Biology: Vol. 4 No. 3 (2025)
- Ezio Zanon, Giancarlo Castaman, Augusto Bramante Federici, Maria Elisa Mancuso, Gianfranco Pasut, Alberto Tosetto, Angiola Rocino, Rita Carlotta Santoro, Bioequivalence of von Willebrand factor-containing concentrates: implications for the choice in patients with von Willebrand disease. A position paper from the Italian Association of Hemophilia Centers , Bleeding, Thrombosis and Vascular Biology: Vol. 5 No. 1 (2026)
